2.2 Anesthetic Agents, Reversal Drugs, and Toxicity Recognition
Key Takeaways
- Ambulatory anesthesia favors short-acting agents, but short duration never eliminates the need to monitor for respiratory depression, hypotension, nausea, delayed emergence, and recurrent sedation.
- Know the reversal target: naloxone reverses opioids, flumazenil reverses benzodiazepines, neostigmine or sugammadex reverse selected nondepolarizing neuromuscular blockers, and dantrolene treats malignant hyperthermia.
- Local anesthetic systemic toxicity can begin with neurologic symptoms and progress to seizures, dysrhythmias, and cardiovascular collapse; early recognition and lipid emulsion readiness are key.
- Drug judgment on CAPA is usually scenario based: choose the response that supports oxygenation and circulation first, then treats the specific medication problem.
Medication judgment, not rote memorization
CAPA pharmacology questions usually place the nurse at the bedside. The stem may describe a patient who is too sleepy, hypoventilating, hypotensive, weak after a block, nauseated, confused, or developing a rare emergency. The correct answer is the one that matches the drug effect and protects the patient while the team intervenes.
Common ambulatory anesthetic agents
| Drug or class | Why it is used | Watch for |
|---|---|---|
| Propofol | Rapid onset, short duration, smooth emergence, antiemetic tendency | Respiratory depression, apnea, hypotension, no analgesia. |
| Midazolam | Anxiolysis, amnesia, sedation | Respiratory depression when combined with opioids, prolonged sedation in older adults, paradoxical agitation. |
| Fentanyl and other opioids | Analgesia during and after procedures | Respiratory depression, nausea, pruritus, urinary retention, recurrent sedation after reversal. |
| Ketamine | Analgesia and dissociative sedation with relative preservation of airway reflexes | Emergence reactions, salivation, hypertension or tachycardia in some patients. |
| Dexmedetomidine | Sedation with limited respiratory depression and some analgesic-sparing effect | Bradycardia, hypotension, delayed wakefulness. |
| Etomidate | Hemodynamically stable induction in selected patients | Myoclonus, nausea, adrenal suppression concern with repeated/prolonged use. |
| Volatile agents | General anesthesia maintenance | Postoperative nausea, airway irritation, malignant hyperthermia trigger in susceptible patients. |
| Nitrous oxide | Analgesic adjunct with rapid offset | Expansion of air-filled spaces and diffusion hypoxia if oxygenation is not managed. |
Reversal agents: match the antidote to the exposure
Reversal medications can be lifesaving, but they do not replace airway management. If the patient is obstructing or apneic, open the airway, provide oxygen, stimulate, and assist ventilation while the cause is addressed.
| Problem | Reversal or treatment | CAPA cautions |
|---|---|---|
| Opioid oversedation or respiratory depression | Naloxone | Shorter duration than many opioids; monitor for recurrent sedation, pain, sympathetic surge, and withdrawal in opioid-tolerant patients. |
| Benzodiazepine oversedation | Flumazenil | Can precipitate seizures in patients with chronic benzodiazepine use or mixed overdoses; monitor for resedation. |
| Residual nondepolarizing neuromuscular blockade | Neostigmine with anticholinergic co-medication or sugammadex for rocuronium/vecuronium | Persistent weakness can impair ventilation and airway protection; use objective assessment per facility practice. |
| Malignant hyperthermia | Stop triggers, call for help, dantrolene, active cooling, correct acidosis/hyperkalemia | Rigidity, rising carbon dioxide, tachycardia, hyperthermia, acidosis, and hyperkalemia are emergency clues. |
| Local anesthetic systemic toxicity | Stop injection, airway/oxygenation support, seizure control, lipid emulsion, cardiovascular support | Early neurologic symptoms can precede cardiovascular collapse. |
Local anesthetic duration and dose thinking
Local anesthetics differ by onset, duration, potency, and cardiotoxicity. CAPA questions rarely require a full pharmacology table, but they do expect recognition of short-acting versus long-acting choices and toxicity risk.
| Agent | Common role | Practical point |
|---|---|---|
| Lidocaine | Local infiltration, topical, short procedures | Fast onset and shorter duration; epinephrine may prolong effect and reduce systemic absorption. |
| Mepivacaine | Peripheral nerve blocks and infiltration | Intermediate duration; less vasodilation than lidocaine. |
| Bupivacaine | Peripheral nerve blocks and longer postoperative analgesia | Long duration; higher cardiotoxicity concern if systemic toxicity occurs. |
| Ropivacaine | Peripheral nerve blocks, postoperative analgesia | Long acting with less motor block tendency than bupivacaine in some uses, but toxicity is still possible. |
Local anesthetic systemic toxicity (LAST) may begin with circumoral numbness, metallic taste, tinnitus, dizziness, agitation, confusion, or tremor. It can progress to seizures, bradycardia, ventricular dysrhythmias, hypotension, and cardiac arrest. The nurse should stop administration if occurring in the nurse's scope, call for help, support oxygenation and ventilation, prepare lipid emulsion according to protocol, and anticipate seizure and cardiovascular management.
Highly vascular injection sites, large total doses, accidental intravascular injection, extremes of age, pregnancy, low muscle mass, hepatic dysfunction, and cardiac disease can increase toxicity risk. Epinephrine may reduce systemic absorption and can serve as an intravascular marker, but it does not make excessive dosing safe.
Neuromuscular blockers and residual weakness
Residual blockade matters in ambulatory recovery because the patient may look awake but still be unable to maintain ventilation, clear secretions, or protect the airway. Clues include weak hand grasp, inability to sustain head lift if assessed, shallow breathing, diplopia, difficulty swallowing, and low oxygen saturation despite wakefulness.
Succinylcholine is a depolarizing neuromuscular blocker with rapid onset and short expected duration. A patient with pseudocholinesterase deficiency can have prolonged paralysis and apnea after succinylcholine. Nondepolarizing agents such as rocuronium or vecuronium may be reversed by sugammadex; neostigmine is used for selected nondepolarizing blockade with an anticholinergic to reduce muscarinic effects.
Malignant hyperthermia vs. other emergencies
Malignant hyperthermia is rare but high-stakes. It is associated with susceptible patients exposed to triggering agents such as volatile anesthetics or succinylcholine. Early signs may include unexpected rise in end-tidal carbon dioxide, tachycardia, muscle rigidity, acidosis, hyperkalemia, and later hyperthermia.
Do not confuse malignant hyperthermia with local anesthetic toxicity or routine fever. LAST points toward neurologic symptoms after local anesthetic exposure and dysrhythmias or seizures. Malignant hyperthermia points toward hypermetabolism after triggering general anesthetics, with dantrolene as the specific treatment.
Recovery implications of reversal
A patient who receives a reversal agent is not automatically ready for discharge. Naloxone and flumazenil may wear off before the sedative or opioid does. Reversal can also unmask pain, agitation, hypertension, nausea, or withdrawal. The patient needs continued monitoring until ventilation, oxygen saturation, mental status, pain control, and vital signs remain stable without repeated rescue.
For exam purposes, choose answers that respect the ABCs first. Medication reversal is appropriate when indicated, but it is usually paired with airway support, team notification, monitoring, and reassessment.
A patient who received fentanyl and midazolam for an ambulatory procedure is difficult to arouse, has snoring respirations, and an oxygen saturation of 88%. What is the nurse's priority action?
Match each medication problem with the most specific expected treatment or reversal agent.
Match each item on the left with the correct item on the right
Ten minutes after a high-volume local anesthetic injection for a block, a patient reports ringing in the ears and a metallic taste, then becomes increasingly confused. Which concern should the nurse escalate first?